The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study.

Kaplan M. A., Oruc Z., Gumus M., Ozaydm S., ELKIRAN E. T., Dine N. S., ...More

Journal of B.U.ON. : official journal of the Balkan Union of Oncology, vol.24, no.3, pp.1081-1086, 2019 (SCI-Expanded) identifier identifier identifier


Purpose: To analyze the reliability and the effectiveness of chemotherapy and prognostic factors for survival in patients with HER2 (human epidermal growth receptor 2) negative early-stage breast cancer treated with adjuvant sequential anthracycline-based chemotherapy and paclitaxel.